The Opioid Peptide Dynorphin A Boosts Immune Cell Multiplication and IL-2 Production
Dynorphin A enhanced immune cell proliferation and IL-2 production in rat spleen cells, establishing it as an immune-stimulating opioid peptide alongside the better-studied endorphins and enkephalins.
Quick Facts
What This Study Found
Dynorphin A enhanced mitogen-induced proliferation of rat splenocytes and increased IL-2 production, demonstrating immunostimulatory activity for this previously undercharacterized opioid peptide.
Key Numbers
How They Did This
In-vitro study measuring proliferative response and IL-2 production of rat splenocytes treated with dynorphin A in the presence of mitogens (ConA, PHA).
Why This Research Matters
This expands understanding of how the opioid system regulates immunity. Dynorphin A's immune-boosting effect suggests all three major opioid peptide families participate in immune regulation, each potentially through different mechanisms.
The Bigger Picture
The opioid-immune connection is increasingly recognized as important for understanding how stress, pain, and addiction affect immune function. All three opioid peptide families — endorphins, enkephalins, and dynorphins — now have documented immune effects.
What This Study Doesn't Tell Us
In-vitro study using rat splenocytes with mitogen stimulation. Effects in vivo and in human immune cells may differ. The specific opioid receptor subtype mediating the effect was not identified.
Questions This Raises
- ?Which opioid receptor mediates dynorphin A's immune-stimulating effect?
- ?Does chronic stress-induced dynorphin changes affect immune function?
- ?Could dynorphin analogs be developed as immune modulators?
Trust & Context
- Key Stat:
- IL-2 boosted Dynorphin A increased production of IL-2, a critical immune signaling molecule, in addition to enhancing cell proliferation
- Evidence Grade:
- Preliminary in-vitro evidence demonstrating a clear immunostimulatory effect for dynorphin A, filling a gap in opioid peptide immunology.
- Study Age:
- Published in 1999. Opioid-immune interactions continue to be studied, with relevance to pain management, addiction, and immunology.
- Original Title:
- Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes.
- Published In:
- Neuropeptides, 33(2), 137-43 (1999)
- Database ID:
- RPEP-00545
Evidence Hierarchy
Frequently Asked Questions
What is dynorphin A?
Dynorphin A is a natural opioid peptide produced in the brain and body. It primarily activates kappa-opioid receptors and is involved in stress responses, pain modulation, and now immune function.
How does this connect pain to immunity?
The body's opioid peptides, including dynorphin A, affect both pain and immune function. This means conditions that alter opioid peptide levels — like chronic pain or stress — could also affect immune health.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00545APA
Ni, X; Lin, B C; Song, C Y; Wang, C H. (1999). Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes.. Neuropeptides, 33(2), 137-43.
MLA
Ni, X, et al. "Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes.." Neuropeptides, 1999.
RethinkPeptides
RethinkPeptides Research Database. "Dynorphin A enhances mitogen-induced proliferative response ..." RPEP-00545. Retrieved from https://rethinkpeptides.com/research/ni-1999-dynorphin-a-enhances-mitogeninduced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.